Domestic manufacturing edge AdvaStim markets itself as a trusted domestic source for neuromodulation device development through its AdvaStim-X design and manufacturing partnerships, appealing to US-based developers seeking regulatory-aligned, near-shore supply chains. Sales angles include contract manufacturing, design-for-manufacturing collaboration, and supply chain risk mitigation for startups and OEMs.

Customizable platform advantages The ASICore multi-channel switching and electrode programming with ASIControl embedded software enable rapid customization of stimulation waveforms and electrode configurations across indications, shortening development cycles. This creates sales opportunities in co-development, IP licensing, integration and qualification services, and waveform optimization consulting.

Market opportunity AdvaStim targets a multi-billion neurostimulation market with a modular system architecture that supports cost-effective customization for multiple clinical indications, enabling clients to adapt the platform across therapies without redesigning core hardware. This opens cross-indication licensing, platform-level collaborations, and expansion into adjacent indications.

Strategic alliances The appointment of George Cintra as Strategic Advisor for Technology and Business Development signals a proactive BD approach and potential access to alliance partners and commercialization opportunities. Use this to propose joint development, distribution partnerships, and channel alliances leveraging existing networks.

Customer revenue path With minimal internal staff, AdvaStim can monetize through partnerships with neurostimulation startups, device OEMs, and contract manufacturers by licensing IP, providing engineering services, and fulfilling manufacturing collaborations to accelerate time-to-market for implantable therapies.